Wells Fargo lowered the firm’s price target on Accelerant (ARX) to $23 from $28 and keeps an Equal Weight rating on the shares. The firm notes Accelerant traded down 26% as EBITDA guide for Q3 was lower than its estimate and Hadron remains a substantial portion of third-party premium. Third party premium growth ex Hadron was 140% vs 12% in Q1.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant Holdings Reports Strong Q2 2025 Results
- Buy Rating for Accelerant Holdings: Strong Financial Performance and Growth Potential Highlighted
- Accelerant reports Q2 EPS 4c, consensus 12c
- Accelerant Holdings Class A: Strategic Growth Through Direct Commission Income and Third-Party Capital Partnerships
- CVS Health upgraded, Occidental downgraded: Wall Street’s top analyst calls